A Virtual Farewell Tribute to NIH Director Dr. Francis Collins
On October 5, 2021, NIH announced that Francis S. Collins, M.D., Ph.D., had made the decision to end his tenure as the NIH director by the end of the year. His last day as NIH director is December 19, 2021. Dr. Collins is the longest serving, presidentially appointed NIH director, having served three U.S. presidents over more than 12 years.
Видео A Virtual Farewell Tribute to NIH Director Dr. Francis Collins канала NIH VideoCast
Видео A Virtual Farewell Tribute to NIH Director Dr. Francis Collins канала NIH VideoCast
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![Gaining New Insights into 'Fundamental Immunology' Using Imaging and Computation](https://i.ytimg.com/vi/pWT98jkY0a4/default.jpg)
![Heterogeneity of Breast Cancer Genomes](https://i.ytimg.com/vi/mh4NH4q9QU0/default.jpg)
![Quality Management in Clinical Research: Preparing for a Successful Quality Visit Part 2](https://i.ytimg.com/vi/3SVjq_tzxNQ/default.jpg)
![Data and Safety Monitoring Committees: Trials Needing DSMBs Part 4](https://i.ytimg.com/vi/oWK_q84I_6Y/default.jpg)
![2018 Demystifying Medicine: Compulsive disorders: mechanisms and management](https://i.ytimg.com/vi/66AYPnccN2Q/default.jpg)
![Antibodies Against Ebola and Lassa: A Global Collaboration](https://i.ytimg.com/vi/Zzy-BCMCed8/default.jpg)
![Neuronal Response to Injury and Stress: Insights from C. elegans](https://i.ytimg.com/vi/T_wKKzIX_N0/default.jpg)
![Study Participant Selection: Example of Participant Selection Part 3](https://i.ytimg.com/vi/uO6MF_9YQG0/default.jpg)
![Choosing a Research Question: Developing a Hypothesis and Objectives Part 3](https://i.ytimg.com/vi/eeRV-t0smt8/default.jpg)
![In Vitro Approaches to Investigate Cell Division and Biological Size Control](https://i.ytimg.com/vi/MqckH7AIoN8/default.jpg)
![Data Management & Case Report in Clinical Trials: CRF Completion and Query Resolution Part 3](https://i.ytimg.com/vi/khl72phrKFY/default.jpg)
![Quality of Life: Patient Reported Outcomes: Purpose, Types, Development, and Evaluation Part 1](https://i.ytimg.com/vi/4mcaUOMBDRo/default.jpg)
![Medal Winners: How the Vietnam War Launched Nobel Careers](https://i.ytimg.com/vi/cSRDwF5kuLI/default.jpg)
![Quality of Life: Interpretation of PRO Scores Part 3](https://i.ytimg.com/vi/KlK-ky_NSJw/default.jpg)
![Developing Protocols & Manuals of Operating Procedures: Informed Consent & Conclusions Part 5](https://i.ytimg.com/vi/evLzCOF39lk/default.jpg)
![Introduction to Clinical Study Design: Tips for Good Study Design Part 4](https://i.ytimg.com/vi/rWAF8tbc_kA/default.jpg)
![Designing Trials Efficiently: Review of Sample Size Considerations Part 2.](https://i.ytimg.com/vi/YzgRxYKenC8/default.jpg)
![Research With Vulnerable Participants: Vulnerabilities and Safeguards Part 2](https://i.ytimg.com/vi/b-2EL8nFlEw/default.jpg)
![Demystifying Medicine 2015 - New Advances in Cancer Diagnosis and Treatment (Immunotoxins)](https://i.ytimg.com/vi/kqDY8J_HMEU/default.jpg)
![IPPCR 2019 Overview of Hypothesis Testing Part 4 of 5](https://i.ytimg.com/vi/nMo6vbZnGu4/default.jpg)
![Is the Study of Monogenic Diseases of the Immune System Relevant?](https://i.ytimg.com/vi/QDsudn46vi8/default.jpg)